Tatyana Feldman, M.D.

Tatyana Feldman, M.D. specializes in the treatment of lymphoma, including Hodgkin's disease and non-Hodgkin's lymphoma. She joined the John Theurer Cancer Center in 2006, bringing more than 15 years of experience in internal medicine, hematology, and oncology. Dr. Feldman currently serves as an Attending in the Lymphoma Division at the John Theurer Cancer Center. Prior to her current position, Dr. Feldman was on faculty in Hematology Division at NYU Medical center.

Dr. Feldman is actively involved in research related to lymphoma. She has presented at medical meetings, including some of the most well-known in the world, such as the American Society of Hematology. In addition, she is currently the principal investigator for a number of clinical trials being conducted at the John Theurer Cancer Center. Her research interests include finding new therapies for lymphomas including some rare lymphomas such as T cell lymphoma, cutaneous and EBV-driven lymphomas.

Throughout her career, Dr. Feldman has been actively involved in the fostering the educational development of physicians and nurses. She has taught courses to medical students, conducted lectures at NYU Downtown Hospital and Hackensack University Medical Center, and trained residents and fellows at NYU School of Medicine and UMDNJ School of Medicine.

Dr. Feldman completed her internship and residency at the Beth Israel Medical Center and was honored with the position of Chief Resident while there, before undergoing a fellowship at the NYU School of Medicine. Dr. Feldman conducted her medical training at Minsk State Medical School where she received a Medical School Diploma with Honors. Click here for a list of John Theurer Cancer Center Lymphoma clinical trials.